PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2003 | 182 |
| 2004 | 160 |
| 2005 | 132 |
| 2006 | 209 |
| 2007 | 329 |
| 2008 | 359 |
| 2009 | 430 |
| 2010 | 285 |
| 2011 | 126 |
| 2012 | 278 |
| 2013 | 216 |
| 2014 | 235 |
| 2015 | 248 |
| 2016 | 255 |
| 2017 | 343 |
| 2018 | 434 |
| 2019 | 369 |
| 2020 | 481 |
| 2021 | 462 |
| 2022 | 435 |
| 2023 | 362 |
| 2024 | 373 |
| 2025 | 320 |
| 2026 | 260 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Cancer Sci"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Dioscin Promotes Ferroptosis in Cervical Cancer Cells via the TIGAR-ROS Axis.
- Liu Y, Xi H, Min S, Yang H, Hou L, Zhang H, Tan Y.
- Cancer Sci. 2026 Oct 23:10.1111/cas.70560. doi: 10.1111/cas.70560. Online ahead of print.
- PMCID: PMC13693567
Liu Y, et al.Cancer Sci. 2026.PMCID: PMC13693567 -
A Transgenic Rat Model of DXd ADC-Related Interstitial Pneumonitis for Mechanistic and Translational Research.
- Kumagai K, Nagai Y, Shirai Y, Fujimoto K, Imaoka M, Chiba K.
- Cancer Sci. 2026 Oct 23:10.1111/cas.70572. doi: 10.1111/cas.70572. Online ahead of print.
- PMCID: PMC13694179
Kumagai K, et al.Cancer Sci. 2026.PMCID: PMC13694179 -
Higher LSD1 in Non-Seminomatous Germ Cell Tumors and LSD1 Inhibition by NCL1 Suppresses Embryonal Carcinoma Growth.
- Shimizu N, Etani T, Naiki T, Naiki-Ito A, Sugiyama Y, Nagai T, Murakami A, Kato H, Morikawa T, Aoki M, Gonda M, Suzuki H, Tsubouchi Y, Ishikawa D, Suzuki T, Takahashi S, Yasui T.
- Cancer Sci. 2026 Oct 21:10.1111/cas.70569. doi: 10.1111/cas.70569. Online ahead of print.
- PMCID: PMC13687810
Shimizu N, et al.Cancer Sci. 2026.PMCID: PMC13687810 -
Advances in the Role of Chemokines in Microwave Ablation-Based Combinatorial Immunotherapy.
- An R, He N, Gu W.
- Cancer Sci. 2026 Oct 19:10.1111/cas.70565. doi: 10.1111/cas.70565. Online ahead of print.
- PMCID: PMC13680724
An R, et al.Cancer Sci. 2026.PMCID: PMC13680724 -
Distinct Clinicogenomic Contexts of BRAF-Altered Gliomas and Glioneuronal Tumors: A Nationwide Real-World Study.
- Yamada S, Takimoto T, Ueno S, Minamiguchi S, Ohba S, Hirose Y, Saya H, Sudo T.
- Cancer Sci. 2026 Oct 18:10.1111/cas.70568. doi: 10.1111/cas.70568. Online ahead of print.
- PMCID: PMC13678126
Yamada S, et al.Cancer Sci. 2026.PMCID: PMC13678126 -
Evolution of CAR-T Therapy: Functional Engineering, Manufacturing Innovation, and Future In Vivo Strategies.
- Sakoda Y.
- Cancer Sci. 2026 Oct 18:10.1111/cas.70567. doi: 10.1111/cas.70567. Online ahead of print.
- PMCID: PMC13677979
Sakoda Y.Cancer Sci. 2026.PMCID: PMC13677979 -
CDK4/6 Inhibitors and Curcumin Synergistically Suppress HER2- Breast Cancer via Lethal ROS and Inhibition of Metastasis.
- Wang C, Zou Y, Chang C, Liu S, Ke X, Hu L, Wang D, Lu Y, Luo S, Huang S, Hu Y, Yu W, Deng A, Yue M, Jiang J.
- Cancer Sci. 2026 Oct 18:10.1111/cas.70557. doi: 10.1111/cas.70557. Online ahead of print.
- PMCID: PMC13677612
Wang C, et al.Cancer Sci. 2026.PMCID: PMC13677612 -
The Serotonergic and Cholinergic Signaling Pathways Drive Gastric Precancerous Lesions and Its Potential Mechanism.
- Gao S, Feng X, Zhang N, Su J, Wang Y, Kong L, Zhou J, Dong H, Guo F.
- Cancer Sci. 2026 Oct 17:10.1111/cas.70563. doi: 10.1111/cas.70563. Online ahead of print.
- PMCID: PMC13675666
Gao S, et al.Cancer Sci. 2026.PMCID: PMC13675666 -
Real-World Germline Variant Landscape and Clinical Management in Korean Patients Tested for Suspected Hereditary Cancer.
- Kang MC, Lee HE, Park SY, Lee S, Jung SY, Lim MC, Kang HS, Seol CA, Jang JH, Woo SM, Joung JY, Choi W, Park SC, Kong SY.
- Cancer Sci. 2026 Oct 16:10.1111/cas.70562. doi: 10.1111/cas.70562. Online ahead of print.
- PMCID: PMC13675117
Kang MC, et al.Cancer Sci. 2026.PMCID: PMC13675117 -
Distinct Clinical Features of Multiple Myeloma With t(11;14): A Post Hoc Analysis of JSH-MM-15 Study.
- Tsukamoto T, Shimura Y, Mizutani S, Fujino T, Okamoto H, Itagaki M, Handa H, Shimizu T, Sawamura M, Ishida T, Kosugi S, Ota S, Yoshimitsu M, Shimazu Y, Sugiura I, Shibayama H, Fuchida SI, Takamatsu H, Saito AM, Kiyoi H, Akashi K, Matsumura I, Takaori-Kondo A, Kuroda J, Iida S.
- Cancer Sci. 2026 Oct 15:10.1111/cas.70564. doi: 10.1111/cas.70564. Online ahead of print.
- PMCID: PMC13673057
Tsukamoto T, et al.Cancer Sci. 2026.PMCID: PMC13673057